Global Genetic Toxicity Testing Market 2022 Future Trend, Business Strategies, Revenue Value, Comprehensive Analysis and Forecast by 2030

SDKI Inc. published a new report on the Global Genotoxicity Testing Market-Forecast 2022-2030. This study includes the statistical and analytical approaches needed to grow the genotoxicity testing market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-111553

The genetic toxicity testing market is estimated to reach US $ 2.61 billion by 2030 from a market value of US $ 1.32 billion in 2022 and is expected to grow at a CAGR of 10.2% during the 2022-2030 forecast period.

Genotoxicity is the effect of biological, physical and chemical agents on the inheritance of organisms. I will handle it. Genotoxicology is the study of the toxic effects of damage to deoxyribonucleic acid (DNA). Genotoxicity plays a vital role in the R & D department, as numerous trials are being conducted to design and develop drugs. These tests will help you discover new vaccines and drugs.

Report sample URL
https://www.sdki.jp/sample-request-111553

Increased drug discovery and development will drive the growth of the genotoxicity testing market. In addition, increased demand for genotoxicity testing is increasing due to increased R & D activities in pharmaceuticals and increased investment in medical research. In addition, the growing number of genotoxicity testing applications in various end-use industries such as the healthcare, cosmetics, and food industries will drive the growth of the genotoxicity testing market. Growth in the food processing industry and demand for cosmetics are expected to drive the growth of the genotoxicity testing market. In addition, the growing global demand for humanized animal models creates favorable growth opportunities for the genotoxicity testing market. However, the lack of validated in vitro models for studying complex endpoints can curb the growth of the genotoxicity testing market.

According to FEBEA (French trading organization of cosmetics and perfumes companies) in 2018, there were 430 cosmetics companies in France. Meanwhile, the gross domestic product of cosmetics in Japan was $ 21.75 billion in 2016, but increased to $ 22.18 billion in 2017 and $ 22.23 billion in 2018. According to Cosmetica Italia of the Italian Cosmetic Industry Association, there are 123,000 cosmetic companies in the country, and the total production of local cosmetics in Italy in 2016 was US $ 11.6 billion, but increased to US $ 12.3 billion in 2017. ..

Genotoxicity Testing Market Segment

The genotoxicity testing market is divided by product (assays, reagents and consumables, services), by application (healthcare, food, cosmetics, agricultural) and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional overview

The genotoxicity testing market The genotoxicity testing market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.

Details of the research report
https://www.sdki.jp/reports/genetic-toxicology-testing-market/111553

North America is the world's leading region in terms of market share. This is due to increased development of structure-based drug design and increased academic and government investment in genomics and proteomics research. Meanwhile, the Asia Pacific genotoxicity testing market is expected to register the largest CAGR during the forecast period (2022-2030). Factors such as high biopharmacy R & D costs and new adoption of advanced technology create favorable growth opportunities for the genotoxicity testing market in the Asia-Pacific region.

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

This release was published on openPR.